evenfolioETF Details
iShares·Health·IBRN · NYSE Arca
iShares Neuroscience and Healthcare ETF (IBRN)
- Price
- $33.33
- —25 Sept 2026
- Assets
- $7.8M
- Total net assets
- Expense ratio
- 0.47%
- Category 1.00%
- Yield
- 0.82%
- Trailing distributions
- 1Y return
- 31.7%-4.3%
- Category 36.0%
- 3Y CAGR
- 17.3%+0.8%
- Category 16.5%
- 5Y CAGR
- —
- Category 2.9%
Loading NAV history…
iShares Neuroscience and Healthcare ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -17.4% | -12.8% | +8.0% | +3.1% | +31.7% | +17.3% | — | — | +8.5% |
| Health average | -3.2% | 5.9% | 25.6% | 16.1% | 36.0% | 16.5% | 2.9% | 9.1% | 11.4% |
| Difference | -14.2% | -18.7% | -17.6% | -13.0% | -4.3% | +0.8% | — | — | -3.0% |
Holdings
The 10 largest positions make up 45.0% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 5.21% |
| DNTH | Dianthus Therapeutics Inc | 4.96% |
| ACAD | ACADIA Pharmaceuticals Inc | 4.93% |
| SRRK | Scholar Rock Holding Corp | 4.85% |
| XENE | Xenon Pharmaceuticals Inc | 4.40% |
| ARGX | argenx SE ADR | 4.38% |
| ARWR | Arrowhead Pharmaceuticals Inc | 4.26% |
| BIIB | Biogen Inc | 4.19% |
| ALKS | Alkermes PLC | 4.15% |
| PTCT | PTC Therapeutics Inc | 3.70% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 4.4
- P/S
- 5.2
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- iShares
- Category
- Equity · Health
- Ticker
- IBRN
- Exchange
- NYSE Arca
- Inception
- 24 Aug 2022 (4.1 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.47% (category 1.00%)
- Holdings turnover
- 52% (category 51%)
- Distribution yield
- 0.82%
- Beta, 3 years
- 0.87
- Total net assets
- $7.8M
Prices and returns as of 25 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- HLTH · Tema Healthcare AI ETFTema ETFs · $7.7M
- THNR · Amplify Weight Loss Drug & Treatment ETFAmplify ETFs · $5.3M · ER 0.59%
- EKG · First Trust Nasdaq Lux Digital Health Solutions ETFFirst Trust · $4.4M · ER 0.65%
- NVOH · Novo Nordisk A/S (B Shares) ADRhedgedADRH · $3.9M · ER 0.19%
- WDNA · WisdomTree BioRevolution FundWisdomTree · $3.5M · ER 0.45%5Y -0.9%
- MDEV · First Trust Indxx Medical Devices ETFFirst Trust · $3.2M · ER 0.70%5Y -5.4%